Liver Disease
Conference Coverage
Study examines intestinal microbiota role post liver transplant
Colonization by multidrug-resistant organisms has a large effect on infections, microbiome diversity, and transplant outcomes.
Conference Coverage
Nivolumab may extend survival in HCC patients
WASHINGTON – About 20% of patients achieved an objective remission that included complete responses in all subgroups of patients.
From the Journals
Case study suggests maternal inheritance of PBC susceptibility
Screening with antimitochondrial-antibody and liver-function tests should be recommended to other family members for early detection and...
Conference Coverage
Emerging oral agent reduces ALT in NAFLD
In phase 2 dose-finding study, hepatic fraction decreased in treated patients.
Conference Coverage
Novel metabolite may be key in NAFLD
The gut microbiome–derived metabolite may be a useful biomarker.
Conference Coverage
Hispanics bear brunt of NAFLD disease burden
Relative risk of NAFLD is higher in Hispanics, but the risk of death from NAFLD is highest in whites.
Conference Coverage
VIDEO: Metabolic regulator FGF21 improves fibrosis in NASH patients
A hormone is found to help with NASH-related fibrosis and liver injury.
Conference Coverage
Middle-aged hepatocellular carcinoma patients increasingly ineligible for transplant
WASHINGTON – Baby boomers show a disparity between high risk of HCC and low rate of meeting the Milan criteria.
Conference Coverage
VIDEO: Liver transplant center competition tied to delisting patients
See how competition among transplant centers can help listed patients.
Conference Coverage
VIDEO: Huge database analysis affirms genes associated with NAFLD
WASHINGTON – A genome-wide association study of the MVP confirmed three specific genes associated with nonalcoholic fatty liver disease.